E-MOHS Trial of TENS and Vibration During Local Anesthesia
Part of paid clinical trials in Maple Grove, Minnesota.
- Sponsor
- University of Minnesota
- Study ID
- NCT07852455
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
- Local Anesthesia
- Mohs Surgery
- Pain
- Procedural Pain
- Skin Cancer
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Active Vibration:TENS — DEVICEActive high-frequency transcutaneous electrical nerve stimulation will be applied with adhesive electrodes placed outside the sterile field during local anesthetic infiltration. Stimulation will be titrated to a strong but comfortable, non-painful paresthesia and used with vibratory distraction adjacent to the injection site.
- Sham TENS — DEVICESham transcutaneous electrical nerve stimulation will use a transient fade-to-zero current so that device titration appears similar to active treatment while preserving participant blinding.
Study Details
The E-MOHS Trial is a randomized controlled trial evaluating whether active vibration plus transcutaneous electrical nerve stimulation reduces pain during local anesthetic infiltration in adults undergoing Mohs micrographic surgery or dermatologic excision. Participants will be randomized to active vibration:TENS or sham TENS during the first local anesthetic administration. The primary outcome is patient-reported infiltration pain during active local anesthetic infiltration, measured using the 11-point Numeric Rating Scale. Secondary outcomes include infiltration pain measured using a Visual Analog Scale, perioperative anxiety, participant satisfaction, willingness to reuse the device, operator-rated ease of use and sterile-field compatibility, blinding integrity, and adverse events.
Key Dates
- First listed
- Oct 1, 2026
- Start date
- Jan 1, 2027
- Status verified
- Oct 2026
- Primary completion
- Jun 30, 2028
- Completion
- Aug 31, 2028
Study Design
- Enrollment
- 90 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- SUPPORTIVE_CARE
Arms
- Experimental: Active Vibration:TENSParticipants will receive adjunctive high-frequency transcutaneous electrical nerve stimulation with vibratory distraction during local anesthetic infiltration for Mohs micrographic surgery or dermatologic excision.
- Sham Comparator: Sham TENSParticipants will receive sham transcutaneous electrical nerve stimulation during local anesthetic infiltration. The sham device will deliver a fade-to-zero transient current to preserve blinding.
Primary Outcome Measure
Pain During Local Anesthetic Infiltration Measured by Numeric Rating Scale [ Time Frame: During active local anesthetic infiltration at the first anesthetic administration ]
Central Contacts
- Andrew Fay612-625-8625
- Ian Maher, MD612-625-8625
Locations (3)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| M Health Fairview Clinic | Maple Grove | Minnesota | 55369 | Andrew Fay |
| M Health Fairview Clinic - Oxboro | Minneapolis | Minnesota | 55420 | - |
| M Health Fairview Clinic - Wyoming | Wyoming | Minnesota | 55092 | Ian Maher, MD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Maple Grove, MN
Related Studies
- Integrated Cancer Repository for Cancer ResearchRecruiting · University of Nebraska · Greenwood Village, Colorado
- Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)Recruiting · Duke University · Palo Alto, California
- Transdiagnostic Cognitive BiomarkersRecruiting · University of Minnesota · Minneapolis, Minnesota
- Alpha Radiation Emitters Device (DaRT) for the Treatment of Cutaneous SCC for Immunocompromised PatientsRecruiting · Alpha Tau Medical LTD. · Gilbert, Arizona